Immune checkpoint inhibitors for treatment of periorbital squamous cell carcinoma.

Immune checkpoint inhibitors for treatment of periorbital squamous cell carcinoma. Br J Ophthalmol. 2023 03; 107(3):320-323.

View in: PubMed